252 research outputs found

    Complementary collider and astrophysical probes of multi-component Dark Matter

    Get PDF
    We study a new physics scenario with two inert and one active scalar doublets,hence a 3-Higgs Doublet Model (3HDM). We impose aZ(2)xZ ' 2(s)ymmetry onto such a 3HDM with one inert doublet odd under theZ(2) transformation and the other odd under the Z '(2)one.Such a construction leads to a two-component Dark Matter (DM) model. It has been shown that, when there is a sufficient mass difference between the two DM candidates, it is possible to probe the light DM candidate in the nuclear recoil energy in direct detection experiments and the heavy DM component in the photon flux in indirect detection experiments. With the DM masses at the electroweak scale, we show that, independently of astrophysical probes, this model feature can be tested at the Large Hadron Collider via scalar cascade decays in2l+is not an element of (T)final states. We study several observable distributions whose shapes hint at the presence of the two different DM candidatesPeer reviewe

    A smoking gun signature of the 3HDM

    Full text link
    We analyse new signals of a 3-Higgs Doublet Model (3HDM) at the Large Hadron Collider (LHC) where only one doublet acquires a Vacuum Expectation Value (VEV), preserving a Z2Z_2 parity. The other two doublets are \textit{inert} and do not develop a VEV, leading to a \textit{dark scalar sector} controlled by Z2Z_2, with the lightest CP-even dark scalar H1H_1 being the Dark Matter (DM) candidate. This leads to the loop induced decay of the next-to-lightest scalar, H2H1ˉH_2 \to H_1 \ell \bar \ell (=e,μ\ell =e,\mu), mediated by both dark CP-odd neutral and charged scalars. This is a smoking-gun signal of the 3HDM since it is not allowed in the 2-Higgs Doublet Model (2HDM) with one inert doublet and is expected to be important when H2H_2 and H1H_1 are close in mass. In practice, this signature can be observed in the cascade decay of the SM-like Higgs boson, hH1H2H1H1ˉh\to H_1 H_2\to H_1 H_1 \ell \bar \ell into two DM particles and di-leptons or hH2H2H1H1ˉˉh\to H_2 H_2\to H_1 H_1 \ell \bar \ell \ell \bar \ell into two DM particles and four-leptons, where hh is produced from gluon-gluon Fusion. In order to test the feasibility of these channels at the LHC, we devise some benchmarks, compliant with collider, DM and cosmological data, for which the interplay between these production and decay modes is discussed. In particular, we show that the resulting detector signatures, \Et \ell \bar \ell or \Et \ell \bar \ell \ell \bar \ell, with the invariant mass of ˉ \ell \bar \ell pairs much smaller than mZm_Z, can potentially be extracted already from Run 3 data and at the High-Luminosity phase of the LHC.Comment: 27 pages, 13 figures. arXiv admin note: text overlap with arXiv:1712.0959

    Abelian symmetries in multi-Higgs-doublet models

    Full text link
    N-Higgs doublet models (NHDM) are a popular framework to construct electroweak symmetry breaking mechanisms beyond the Standard model. Usually, one builds an NHDM scalar sector which is invariant under a certain symmetry group. Although several such groups have been used, no general analysis of symmetries possible in the NHDM scalar sector exists. Here, we make the first step towards this goal by classifying the elementary building blocks, namely the abelian symmetry groups, with a special emphasis on finite groups. We describe a strategy that identifies all abelian groups which are realizable as symmetry groups of the NHDM Higgs potential. We consider both the groups of Higgs-family transformations only and the groups which also contain generalized CP transformations. We illustrate this strategy with the examples of 3HDM and 4HDM and prove several statements for arbitrary N.Comment: 33 pages, 2 figures; v2: conjecture 3 is proved and becomes theorem 3, more explanations of the main strategy are added, matches the published versio

    Saccade frequency response to visual cues during gait in Parkinson's disease: the selective role of attention

    Get PDF
    Gait impairment is a core feature of Parkinson's disease (PD) with implications for falls risk. Visual cues improve gait in PD, but the underlying mechanisms are unclear. Evidence suggests that attention and vision play an important role; however, the relative contribution from each is unclear. Measurement of visual exploration (specifically saccade frequency) during gait allows for real-time measurement of attention and vision. Understanding how visual cues influence visual exploration may allow inferences of the underlying mechanisms to response which could help to develop effective therapeutics. This study aimed to examine saccade frequency during gait in response to a visual cue in PD and older adults and investigate the roles of attention and vision in visual cue response in PD. A mobile eye-tracker measured saccade frequency during gait in 55 people with PD and 32 age-matched controls. Participants walked in a straight line with and without a visual cue (50 cm transverse lines) presented under single task and dual-task (concurrent digit span recall). Saccade frequency was reduced when walking in PD compared to controls; however, visual cues ameliorated saccadic deficit. Visual cues significantly increased saccade frequency in both PD and controls under both single task and dual-task. Attention rather than visual function was central to saccade frequency and gait response to visual cues in PD. In conclusion, this study highlights the impact of visual cues on visual exploration when walking and the important role of attention in PD. Understanding these complex features will help inform intervention development

    The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer

    Get PDF
    To study the potential impact of the combined use of CT and MRI scans on the Gross Tumor Volume (GTV) estimation and interobserver variation. Four observers outlined the GTV in six patients with advanced head and neck cancer on CT, axial MRI, and coronal or sagittal MRI. The MRI scans were subsequently matched to the CT scan. The interobserver and interscan set variation were assessed in three dimensions. The mean CT derived volume was a factor of 1.3 larger than the mean axial MRI volume. The range in volumes was larger for the CT than for the axial MRI volumes in five of the six cases. The ratio of the scan set common (i.e., the volume common to all GTVs) and the scan set encompassing volume (i.e., the smallest volume encompassing all GTVs) was closer to one in MRI (0.3-0.6) than in CT (0.1-0.5). The rest volumes (i.e., the volume defined by one observer as GTV in one data set but not in the other data set) were never zero for CT vs. MRI nor for MRI vs. CT. In two cases the craniocaudal border was poorly recognized on the axial MRI but could be delineated with a good agreement between the observers in the coronal/sagittal MRI. MRI-derived GTVs are smaller and have less interobserver variation than CT-derived GTVs. CT and MRI are complementary in delineating the GTV. A coronal or sagittal MRI adds to a better GTV definition in the craniocaudal directio

    CP violating scalar Dark Matter

    Get PDF
    We study an extension of the Standard Model (SM) in which two copies of the SM scalar SU(2) doublet which do not acquire a Vacuum Expectation Value (VEV), and hence are inert, are added to the scalar sector. We allow for CP-violation in the inert sector, where the lightest inert state is protected from decaying to SM particles through the conservation of a Z(2) symmetry. The lightest neutral particle from the inert sector, which has a mixed CP-charge due to CP-violation, is hence a Dark Matter (DM) candidate. We discuss the new regions of DM relic density opened up by CP-violation, and compare our results to the CP-conserving limit and the Inert Doublet Model (IDM). We constrain the parameter space of the CP-violating model using recent results from the Large Hadron Collider (LHC) and DM direct and indirect detection experiments.Peer reviewe

    Improving Community Healthcare for Patients with Parkinson's Disease: The Dutch Model

    Get PDF
    Because of the complex nature of Parkinson's disease, a wide variety of health professionals are involved in care. Stepwise, we have addressed the challenges in the provision of multidisciplinary care for this patient group. As a starting point, we have gained detailed insight into the current delivery of allied healthcare, as well as the barriers and facilitators for optimal care. To overcome the identified barriers, a tertiary referral centre was founded; evidence-based guidelines were developed and cost-effectively implemented within regional community networks of specifically trained allied health professionals (the ParkinsonNet concept). We increasingly use ICT to bind these professional networks together and also to empower and engage patients in making decisions about their health. This comprehensive approach is likely to be feasible for other countries as well, so we currently collaborate in a European collaboration to improve community care for persons with Parkinson's disease

    Carotid endarterectomy with patch angioplasty versus primary closure in patients with symptomatic and significant stenosis:a systematic review with meta-analyses and trial sequential analysis of randomized clinical trials

    Get PDF
    Background: Patch angioplasty in conventional carotid endarterectomy is suggested to reduce the risk of restenosis and recurrent ipsilateral stroke compared with primary closure. A systematic review of randomized clinical trials is needed to compare outcomes (benefits and harms) of both techniques. Methods: Searches (CENTRAL, PubMed/MEDLINE, EMBASE, and other databases) were last updated 3rd of January 2021. We included randomized clinical trials comparing carotid endarterectomy with patch angioplasty versus primary closure of the arterial wall in patients with a symptomatic and significant (> 50%) carotid stenosis. Primary outcomes are defined as all-cause mortality and serious adverse events. Results: We included 12 randomized clinical trials including 2187 participants who underwent 2335 operations for carotid stenosis comparing carotid endarterectomy with patch closure (1280 operations) versus carotid endarterectomy with primary closure (1055 operations). Meta-analysis comparing carotid endarterectomy with patch angioplasty versus carotid endarterectomy with primary closure may potentially decrease the number of patients with all-cause mortality (RR 0.53; 95% CI 0.26 to 1.08; p = 0.08, best-case scenario for patch), serious adverse events (RR 0.73; 95% CI 0.56 to 0.96; p = 0.02, best-case scenario for patch), and the number of restenosis (RR 0.41; 95% CI 0.23 to 0.71; p < 0.01). Trial sequential analysis demonstrated that the required information sizes were far from being reached for these patient-important outcomes. All the patient-relevant outcomes were at low certainty of evidence according to The Grading of Recommendations Assessment, Development, and Evaluation. Conclusions: This systematic review showed no conclusive evidence of a difference between carotid endarterectomy with patch angioplasty versus primary closure of the arterial wall on all-cause mortality, < 30 days mortality, < 30 days stroke, or any other serious adverse events. These conclusions are based on data from 15 to 35 years ago, obtained in trials with very low certainty according to GRADE, and should be interpreted cautiously. Therefore, we suggest conducting new randomized clinical trials patch angioplasty versus primary closure in carotid endarterectomy in symptomatic patients with an internal carotid artery stenosis of 50% or more. Such trials ought to be designed according to the Standard Protocol Items: Recommendations for Interventional Trials statement (Chan et al., Ann Intern Med 1:200–7, 2013) and reported according to the Consolidated Standards of Reporting Trials statement (Schulz et al., 7, 2010). Until conclusive evidence is obtained, the standard of care according to guidelines should not be abandoned. Systematic review registration: PROSPERO CRD42014013416. Review protocol publication 2019 DOI: https://doi.org/10.1136/bmjopen-2018-026419

    Carotid endarterectomy with primary closure versus patch angioplasty in patients with symptomatic and significant stenosis:protocol for a systematic review with meta-analyses and trial sequential analysis of randomised clinical trials

    Get PDF
    Introduction Use of patch angioplasty in carotid endarterectomy (CEA) is suggested to reduce the risk of restenosis and recurrent ipsilateral stroke. The objective is to conduct a systematic review with meta-analysis and trial sequential analysis as well as Grading of Recommendations Assessment, Development and Evaluation (GRADE) assessments comparing the benefits and harms of CEA with primary closure of the arterial wall versus CEA with patch angioplasty in patients with a symptomatic and significant carotid stenosis.Methods and analysis The review shall be conducted according to this published protocol following the recommendations of the ` Cochrane' and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Randomised clinical trials comparing CEA with primary closure of the arterial wall versus CEA with patch angioplasty (regardless of used patch materials) in human adults with a symptomatic and significant carotid stenosis will be included. Primary outcomes are all-cause mortality at maximal follow-up, health-related quality of life and serious adverse events. Secondary outcomes are symptomatic or asymptomatic arterial occlusion or restenosis, and non-serious adverse events. We will primarily base our conclusions on meta-analyses of trials with overall low risk of bias. However, if pooled point estimates of all trials are similar to pooled point estimates of trials with overall low risk of bias and there is lack of a statistical significant interaction between estimates from trials with overall high risk of bias and trials with overall low risk of bias we will consider the precision achieved in all trials as the result of our meta-analyses.Ethics and dissemination The proposed systematic review will collect and analyse secondary data from published studies therefor ethical approval is not required. The results of the systematic review will be disseminated by publication in a peer-review journal and submitted for presentation at relevant conferences.</p
    corecore